AMA: Stage 2 Proposal Too ‘Cumbersome’

June 25, 2013
The Chicago-based American Medical Association (AMA) officially submitted its comments this week on the proposed rule for Stage 2 of the Medicare/Medicaid meaningful use electronic health record (EHR) program. Overall, the association said it was supportive of widespread adoption and meaningful use of EHRs by physicians, but thought the Stage 2 proposal was too cumbersome and would make successful physician participation extremely difficult.

The Chicago-based American Medical Association (AMA) officially submitted its comments this week on the proposed rule for Stage 2 of the Medicare/Medicaid meaningful use electronic health record (EHR) program. Overall, the association said it was supportive of widespread adoption and meaningful use of EHRs by physicians, but thought the Stage 2 proposal was too cumbersome and would make successful physician participation extremely difficult.

“Due to physicians’ limited ability to exchange data with other health care partners, many of the proposed Stage 2 measures will require extensive manual data entry, which is not an efficient way of practicing medicine or improving quality care outcomes for patients,” AMA Board Chair-elect Steven J. Stack, M.D., said in a statement.

The AMA made several recommendations to the Office of the National Coordinator for Health IT (ONC). Among those suggestions were to ‘delete the high thresholds for new measures and for measures that cannot be met due to the lack of available, affordable, well-tested tools or exchange capabilities.’ The group also asked for the elimination of back-dating the meaningful use penalty program and to establish a number of exemption categories for hardship cases.

Other changes recommended by the AMA were:

  • Evaluate Stage 1 to inform the final Stage 2 requirements;
  • Create more flexibility in meeting measures including exclusion and relevancy factors;  
  • Incorporate more focus on measures within a physician’s control;
  • Include any proposed new measures for Stage 2 in the menu set of options;  
  • Allow a significant good faith effort to meet measures in Stage 2 to count for incentives and for avoiding penalties;    
  • Synchronize and improve the overlapping health IT and quality program requirements; 
  • Establish an appeals process under both the meaningful use and e-prescribing programs; and
  • Reduce the burden and add flexibility in regard to clinical quality measure (CQM) reporting and requiring testing of electronic specifications prior to use of a CQM.  

“Overall, the proposed Stage 2 requirements need to provide more flexibility to foster widespread EHR adoption,” Dr. Stack said in a statement. “Physicians are at varying stages of implementing health IT into their practices and should get credit for making a good faith effort to meet the meaningful use requirements.”

Sponsored Recommendations

A Cyber Shield for Healthcare: Exploring HHS's $1.3 Billion Security Initiative

Unlock the Future of Healthcare Cybersecurity with Erik Decker, Co-Chair of the HHS 405(d) workgroup! Don't miss this opportunity to gain invaluable knowledge from a seasoned ...

Enhancing Remote Radiology: How Zero Trust Access Revolutionizes Healthcare Connectivity

This content details how a cloud-enabled zero trust architecture ensures high performance, compliance, and scalability, overcoming the limitations of traditional VPN solutions...

Spotlight on Artificial Intelligence

Unlock the potential of AI in our latest series. Discover how AI is revolutionizing clinical decision support, improving workflow efficiency, and transforming medical documentation...

Beyond the VPN: Zero Trust Access for a Healthcare Hybrid Work Environment

This whitepaper explores how a cloud-enabled zero trust architecture ensures secure, least privileged access to applications, meeting regulatory requirements and enhancing user...